Harbour Investments’s Pliant Therapeutics PLRX Stock Holding History

Harbour Investments’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$672	Buy	590 +102	+21%	+$124	﹤0.01%	4309
2026 Q1	$615	Buy	+488	New	+$616	﹤0.01%	4212
2024 Q1	–	Sell	-25	Closed	-$453	–	3288
2023 Q4	$453	Hold	25	–	–	﹤0.01%	2942
2023 Q3	$434	Buy	+25	New	+$433	﹤0.01%	2820
2021 Q4	–	Sell	-381	Closed	-$6K	–	3419
2021 Q3	$6K	Buy	381 +31	+9%	+$658	﹤0.01%	2919
2021 Q2	$10K	Buy	350 +2	+0.6%	+$62	﹤0.01%	2741
2021 Q1	$14K	Buy	+348	New	+$11.3K	﹤0.01%	2425

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Harbour Investments's PLRX Position: Q2 2026 in Review

Harbour Investments increased its Pliant Therapeutics (PLRX) stake by 21% in Q2 2026, buying an estimated $124 and bringing the position to 590 shares worth $672. The position accounts for ﹤0.01% of the portfolio, ranked #4309.

Harbour Investments first reported a position in PLRX in Q1 2021 and has held it in 7 quarters since. The position peaked at $14K in Q1 2021. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Harbour Investments held 590 shares of Pliant Therapeutics worth $672 as of Q2 2026.
Harbour Investments bought 102 Pliant Therapeutics shares in Q2 2026, an estimated $124.
Pliant Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4309 holding.
Harbour Investments first reported a position in Pliant Therapeutics in Q1 2021 and has held it in 7 quarters since.
Harbour Investments's Pliant Therapeutics position peaked at $14K in Q1 2021.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.